GlassScriptPhysician profile
Clayton Bishop
NPI 1386136174
$2,833.18
in general payments reported to CMS, 2019-2025
16 companies · $584 in 2025
The $584 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $48.08 · 2021: $256 · 2022: $227 · 2023: $547 · 2024: $867 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,997.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $916.80 | 2022-2025 | Inspire |
| Stryker Corporation | $376.03 | 2019-2023 | Latera, Xpress Ent Dilation System, Xerogel Nasal/Epistaxis 2 Pack |
| Medtronic, INC. | $343.00 | 2023-2025 | Straightshot, Sinuva, Propel |
| Aerin Medical INC. | $307.92 | 2024 | |
| Cochlear Americas | $147.61 | 2022-2023 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Depuy Synthes Sales INC. | $138.90 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $132.13 | 2024-2025 | Dupixent |
| Kyowa Kirin, INC. | $99.59 | 2024 | |
| Mirum Pharmaceuticals, INC. | $85.66 | 2024 | Livmarli |
| Axogen | $61.69 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $51.16 | 2019 | |
| Biomerieux INC | $50.74 | 2025 | Filmarray Torch Module |
| Vertex Pharmaceuticals Incorporated | $47.56 | 2024-2025 | |
| Acclarent, INC | $33.43 | 2019 | |
| Hologic Sales and Service, LLC | $24.00 | 2025 | Coolseal Generator |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.